Evaluation of virologic suppression rates during the COVID-19 pandemic with outpatient interdisciplinary HIV care
- PMID: 34230911
- PMCID: PMC8250635
- DOI: 10.1002/jac5.1422
Evaluation of virologic suppression rates during the COVID-19 pandemic with outpatient interdisciplinary HIV care
Abstract
Introduction: The Coronavirus Disease 2019 (COVID-19) pandemic has presented social distancing challenges leading healthcare systems to adapt and utilize telemedicine platforms more than ever before. Reducing patient exposure to COVID-19 became a primary concern, especially for populations at an increased risk for severe illness, such as human immunodeficiency virus (HIV) positive patients.
Objectives: The primary objective of this study was to measure the impact of pharmacy services including telehealth through the percentage of virologically suppressed patients (HIV ribonucleic acid [RNA] < 200 copies/mL) during the pre-COVID and post-COVID time periods. Secondary objectives included the percentage of patients with undetectable viral loads (HIV RNA < 20 copies/mL), percentage of patients with cluster of differentiation 4 (CD4) cell counts greater than 200 cells/mm3, and changes in CD4 cell counts and percentages pre-COVID and post-COVID.
Methods: This was a retrospective chart review at a single center HIV primary care clinic in Brooklyn, NY evaluating electronic medical records (EMRs) of 211 HIV-positive patients. Pre-COVID was defined as 1 year prior to March 13, 2020, and post-COVID was defined as March 13 to July 20, 2020.
Results: Viral load suppression rates for pre and post-COVID were 88.6% and 85.3%, respectively (P = .28). Undetectable viral load rates for pre and post-COVID were approximately 81.5% and 74.4% (P = .096). Mean CD4 cell counts and percentages were 617 cells/mm3 and 29% for pre-COVID, and 460 cells/mm3 and 22% for post-COVID. CD4 cell counts greater than 200 cells/mm3 pre-COVID and post-COVID was 92.6% and 78.3%, respectively (P = .001).
Conclusion: Utilization of pharmacy services including telehealth, may allow clinical pharmacists to collaboratively provide remote services without jeopardizing patient outcomes. Larger studies are needed to confirm these findings, and display the long-term impact and satisfaction of these services.
Keywords: adherence; collaborative practice; medication management; telehealth.
© 2021 Pharmacotherapy Publications, Inc.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Viral Load Suppression in People Living with HIV Before and During the COVID-19 Pandemic in Brooklyn, New York.AIDS Behav. 2024 Sep;28(9):2961-2969. doi: 10.1007/s10461-024-04385-0. Epub 2024 Jun 5. AIDS Behav. 2024. PMID: 38836987
-
Variation in subsequent viral load testing and outcomes by visit type patterns in the first year of the COVID-19 pandemic at a large academic medical center in North Carolina.Mhealth. 2025 Mar 21;11:18. doi: 10.21037/mhealth-24-69. eCollection 2025. Mhealth. 2025. PMID: 40248755 Free PMC article.
-
Improving adherence and clinical outcomes through an HIV pharmacist's interventions.AIDS Care. 2010 Oct;22(10):1189-94. doi: 10.1080/09540121003668102. AIDS Care. 2010. PMID: 20640958
-
Cardiac Outpatient Care in a Digital Age: Remote Cardiology Clinic Visits in the Era of COVID-19.Curr Cardiol Rep. 2022 Jan;24(1):1-6. doi: 10.1007/s11886-021-01618-9. Epub 2022 Jan 14. Curr Cardiol Rep. 2022. PMID: 35029784 Free PMC article. Review.
-
Integration of outpatient infectious diseases clinic pharmacy services and specialty pharmacy services for patients with HIV infection.Am J Health Syst Pharm. 2016 Jun 1;73(11):757-63. doi: 10.2146/ajhp150701. Epub 2016 Apr 28. Am J Health Syst Pharm. 2016. PMID: 27126831 Review.
Cited by
-
Potential Effects of the Coronavirus Disease 2019 (COVID-19) Pandemic on Human Immunodeficiency Virus (HIV) Transmission: A Modeling Study in 32 US Cities.Clin Infect Dis. 2022 Aug 24;75(1):e1145-e1153. doi: 10.1093/cid/ciab1029. Clin Infect Dis. 2022. PMID: 35016216 Free PMC article.
-
COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus.Infect Dis Clin North Am. 2022 Jun;36(2):397-421. doi: 10.1016/j.idc.2022.01.006. Epub 2022 Feb 1. Infect Dis Clin North Am. 2022. PMID: 35636907 Free PMC article. Review.
-
Telemedicine virologic and immunologic outcomes in people living with HIV (PLWH) in a correctional setting during the SARS-CoV-2 pandemic.BMC Infect Dis. 2025 Feb 28;25(1):289. doi: 10.1186/s12879-025-10686-z. BMC Infect Dis. 2025. PMID: 40021991 Free PMC article.
-
Telehealth and in-person HIV care during the COVID-19 pandemic at a large academic medical center in North Carolina.PLoS One. 2025 Jun 4;20(6):e0320911. doi: 10.1371/journal.pone.0320911. eCollection 2025. PLoS One. 2025. PMID: 40465553 Free PMC article.
-
HIV and COVID-19: review of clinical course and outcomes.HIV Res Clin Pract. 2021 Aug;22(4):102-118. doi: 10.1080/25787489.2021.1975608. Epub 2021 Sep 12. HIV Res Clin Pract. 2021. PMID: 34514963 Free PMC article.
References
-
- World Health Organization (2020). WHO Coronavirus Disease (COVID‐19) Dashboard. https://covid19.who.int. Accessed February 2, 2021.
-
- Centers for Disease Control and Prevention (2020). COVID Data Tracker. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html. Accessed February 2, 2021.
-
- National Center for Immunization and Respiratory Diseases . (2020). Symptoms of Coronavirus. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019‐ncov/symptoms‐testing/symptoms.html. Accessed February 2, 2021.
-
- Centers for Disease Control and Prevention . Providing Care and Treatment for People Living with HIV in Low‐Resource Non‐US Settings During COVID‐19 Pandemic. https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/maintaining-es.... Accessed February 2, 2021.
LinkOut - more resources
Full Text Sources
Research Materials